Standout Papers

Diagnostic criteria for multiple sclerosis: 2010 Revisio... 2001 2026 2009 2017 7.5k
  1. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011)
    Chris H. Polman, Stephen C. Reingold et al. Annals of Neurology
  2. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis (2001)
    W. I. McDonald, Gilles Edan et al. Annals of Neurology
  3. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” (2005)
    Chris H. Polman, Stephen C. Reingold et al. Annals of Neurology
  4. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis (2011)
    Paul O’Connor, Jerry S. Wolinsky et al. New England Journal of Medicine
  5. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. (2001)
    Giancarlo Comi, Massimo Filippi et al. PubMed
  6. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial (2014)
    Christian Confavreux, Paul O’Connor et al. The Lancet Neurology
  7. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial (2016)
    Fred Lublin, David H. Miller et al. The Lancet
  8. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials (2020)
    Ludwig Kappos, Jerry S. Wolinsky et al. JAMA Neurology

Immediate Impact

22 by Nobel laureates 16 from Science/Nature 117 standout
Sub-graph 1 of 12

Citing Papers

Multiple sclerosis
2023 Standout
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
2023 Standout
228 intermediate papers

Works of Jerry S. Wolinsky being referenced

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
2020 Standout
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 Standout
and 57 more

Author Peers

Author Last Decade Papers Cites
Jerry S. Wolinsky 22921 6349 8479 241 27.9k
W. I. McDonald 21988 6125 9862 248 31.3k
Paul O’Connor 18965 4684 6632 148 24.1k
Fred Lublin 29631 7566 10313 239 36.3k
Eva Havrdová 18266 4692 6056 376 22.9k
Richard A. Rudick 15635 4048 5405 210 21.2k
George C. Ebers 22503 6737 7369 351 31.2k
Emmanuelle Waubant 14895 3558 5953 221 20.4k
Michael Hutchinson 13557 3546 6440 293 21.3k
Jeffrey A. Cohen 12816 3095 5496 305 22.0k
Kazuo Fujihara 20185 6190 13371 283 25.1k

All Works

Loading papers...

Rankless by CCL
2026